GlaxoSmithKline Axes 350 Jobs in Overhaul of Drug Research

LONDON, June 11 (Reuters) - GlaxoSmithKline Plc is axing around 350 jobs in research and development as part of an ongoing restructuring programme, Europe’s biggest drugmaker said on Wednesday.

MORE ON THIS TOPIC